AI assistant
Innoviva, Inc. — Director's Dealing 2011
Feb 28, 2011
32090_dirs_2011-02-28_6b07fab5-50af-40e3-928e-a115a9e8339e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: THERAVANCE INC (THRX)
CIK: 0001080014
Period of Report: 2011-02-24
Reporting Person: Winningham Rick E (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-02-24 | Common Stock | M | 135950 | $8.525 | Acquired | 692223 | Direct |
| 2011-02-24 | Common Stock | S | 93100 | $21.45 | Disposed | 599123 | Direct |
| 2011-02-25 | Common Stock | M | 135850 | $8.525 | Acquired | 734973 | Direct |
| 2011-02-25 | Common Stock | S | 50200 | $22.22 | Disposed | 684773 | Direct |
| 2011-02-25 | Common Stock | S | 42000 | $22.74 | Disposed | 642773 | Direct |
| 2011-02-28 | Common Stock | M | 101752 | $8.525 | Acquired | 744525 | Direct |
| 2011-02-28 | Common Stock | S | 29800 | $22.49 | Disposed | 714725 | Direct |
| 2011-02-28 | Common Stock | S | 37200 | $23.49 | Disposed | 677525 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-02-24 | Stock Option (Right to Buy) | $8.525 | M | 135950 | Disposed | 2011-12-08 | Common Stock (135950) | Direct |
| 2011-02-25 | Stock Option (Right to Buy) | $8.525 | M | 135850 | Disposed | 2011-12-08 | Common Stock (135850) | Direct |
| 2011-02-28 | Stock Option (Right to Buy) | $8.525 | M | 101752 | Disposed | 2011-12-08 | Common Stock (101752) | Direct |
Footnotes
F1: Dispositions made pursuant to a plan intended to comply with rule 10b5-1(c).
F2: This transaction was executed in multiple trades at prices from $20.85 to $21.74. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
F3: This transaction was executed in multiple trades at prices from $21.57 to $22.56. The price reported above reflects the weighted average sale price.
F4: This transaction was executed in multiple trades at prices from $22.57 to $22.85. The price reported above reflects the weighted average sale price.
F5: This transaction was executed in multiple trades at prices from $22.09 to $22.99. The price reported above reflects the weighted average sale price.
F6: This transaction was executed in multiple trades at prices from $23.00 to $23.95. The price reported above reflects the weighted average sale price.
F7: Immediately exercisable